Home/Filings/4/0001104659-22-023786
4//SEC Filing

Gutch Michael 4

Accession 0001104659-22-023786

CIK 0001724344other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:05 PM ET

Size

19.1 KB

Accession

0001104659-22-023786

Insider Transaction Report

Form 4
Period: 2021-07-16
Gutch Michael
CFO and Chief Business Officer
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2021-07-1615,9560 total
    Exercise: $15.00Exp: 2028-09-24Common Stock (15,956 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2021-07-16+8,8638,863 total
    Exercise: $2.44Exp: 2031-07-15Common Stock (8,863 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2021-07-16+23,08123,081 total
    Exercise: $2.44Exp: 2031-07-15Common Stock (23,081 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2021-07-1656,5000 total
    Exercise: $5.66Exp: 2029-01-17Common Stock (56,500 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2021-07-16+43,46043,460 total
    Exercise: $2.44Exp: 2031-07-15Common Stock (43,460 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2021-07-1630,0060 total
    Exercise: $6.85Exp: 2028-04-30Common Stock (30,006 underlying)
Footnotes (9)
  • [F1]The option provided for vesting as follows: Twenty-five percent (25%) of the shares subject to the option will vest on December 6, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the last day of the month, subject to Reporting Person continuing to provide service through each such date.
  • [F2]On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,006 shares of issuer's common stock granted to the Reporting Person on May 1, 2018. In exchange, the Reporting Person received a replacement option for 23,081 shares of issuer's common stock, having an exercise price of $2.44 per share.
  • [F3]The shares subject to this option will vest in full on July 16, 2022, subject to the Reporting Person's continuing to provide service through such date.
  • [F4]The option provided for vesting as follows: Twenty-five percent (25%) of the shares subject to the option shall vest on September 25, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
  • [F5]On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,956 shares of issuer's common stock granted to the Reporting Person on September 25, 2018. In exchange, the Reporting Person received a replacement option for 8,863 shares of issuer's common stock, having an exercise price of $2.44 per share.
  • [F6]Ninety-four (94%) of this award will vest on July 16, 2022, and one-third of the remaining shares subject to the option will vest monthly following July 16, 2022, subject to the Reporting Person's continuing to provide service through each such date.
  • [F7]The option provided for vesting as follows: Twenty-five percent (25%) of the shares subject to the option shall vest on January 1, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
  • [F8]On July 16, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 56,500 shares of issuer's common stock granted to the Reporting Person on January 18, 2019. In exchange, the Reporting Person received a replacement option for 43,460 shares of issuer's common stock, having an exercise price of $2.44 per share.
  • [F9]Eighty-five (85%) of this award will vest on July 16, 2022, and one-seventh of the remaining shares subject to the option will vest monthly following July 16, 2022, subject to the Reporting Person's continuing to provide service through each such date.

Issuer

Entasis Therapeutics Holdings Inc.

CIK 0001724344

Entity typeother

Related Parties

1
  • filerCIK 0001687333

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:05 PM ET
Size
19.1 KB